Ginkgo Biloba: What It Claims, What the Evidence Shows, and Who It's Actually For

Ginkgo biloba is one of the most studied herbal supplements in the world. It's also one of the most frequently misapplied. The marketing targets young people wanting enhanced cognition. The evidence base is primarily in older adults with circulatory or cognitive decline.

These are not the same population.

What Ginkgo Actually Does

Ginkgo biloba extract (standardized to 24% ginkgoflavone glycosides, 6% terpene lactones) has two documented mechanisms [1]:

Platelet-activating factor inhibition. Ginkgolides — specific terpenoid compounds in ginkgo — inhibit platelet-activating factor (PAF), reducing platelet aggregation and improving microvascular blood flow. This is the mechanism behind its documented effects in peripheral vascular disease and cerebral blood flow improvement in elderly populations.

Antioxidant activity. Flavonoid components scavenge free radicals and reduce oxidative stress in neural tissue. In the context of age-related oxidative damage accumulation, this matters.

In young, healthy individuals with no circulatory impairment and adequate baseline antioxidant status, these mechanisms add marginal value.

> 📌 The Ginkgo Evaluation of Memory (GEM) Study in JAMA (2008) — the largest randomized controlled trial of ginkgo biloba in elderly adults, covering 3,069 participants over 6 years — found that ginkgo biloba 120mg twice daily did not significantly reduce the incidence of Alzheimer's disease or dementia compared to placebo in community-dwelling elderly adults. [1]

The GEM study is sobering. It doesn't mean ginkgo has no effect — it means it doesn't prevent dementia in already-healthy elderly populations. The therapeutic window appears to be in those with existing mild cognitive impairment or diagnosed cerebral circulation deficits.

What the Smaller Positive Studies Show

Shorter-duration studies (8–24 weeks) have shown:

• Modest improvements in working memory and processing speed in middle-aged adults with subjective cognitive complaints [2]
• Improvement in tinnitus in a subset of patients — potentially via improved cochlear microvascular circulation
• Reduced anxiety in some trials, though effect sizes are small

Who Ginkgo Is Actually Useful For

• Adults 50+ with subjective cognitive decline wanting a conservative, evidence-based option
• Individuals with peripheral circulation issues (cold hands/feet, Raynaud's phenomenon)
• Tinnitus patients with no structural cause identified

When taken as a "brain boost" by a 25-year-old with no baseline cognitive impairment and normal blood flow, the mechanism has no real substrate to work on. Ginkgo addresses specific deficits. If those deficits aren't present, the effect is minimal.

---